Qualix DoT is the research and development pharmaceutical company of Qualix Ventures.
The purpose of Qualix DoT is to explore, drive, and collaborate in world-class innovative projects that come from academic or industrial initiatives by mainly repurposing known compounds for new indications.
It is a new concept in the search for innovative pharmaceutical treatments aimed at meeting unmet health needs, including the fields of rare diseases, neglected diseases and subgroups of patients with prevalent conditions who do not respond to current therapies.
Qualix DoT adopts a collaborative business model whereby it works in partnership with academic, industrial and patients’ organizations.
Projects related to rare diseases, neglected conditions, or special subpopulations require a tailored strategy. At Qualix DoT we help searching the most pragmatic solutions for every special case.
We bring together people and organizations to bridge the gap between science and the commercialization of new therapies. We work to connect the dots.
We can contribute to generate an experimental or clinical proof of concept that will guide a brilliant idea towards an industrialization process and assist at any stage your project encounters a barrier to progress.
Drugs repurposing.
Reusing a known and safe drug is in the interest of all parties, from patients to payers. We seek the appropriate balance so that the desired solution becomes available and accessible, justifying the development efforts and risks of the investors.
By repurposing drugs, new therapies can be developed faster, safer, and less costly.
Small chemicals that have not managed to reach commercialization, are also a matter of our interest.
Innovative formulations and methods of administration.
Since many available compounds require a suitable formulation for a new therapeutic use, we work towards finding the one that optimizes the project needs.
Care in the acceptance and compliance with therapies is challenging for every use, therefore a formulation shall be designed considering the patients preferences.
With the aim of making a project sustainable, we strive for innovations, significant improvements, and generate intellectual property if possible.
Active Pharmaceutical Ingredients (APIs) and Investigational Medicinal Products (IMPs) supply.
There are well-known challenges regarding access to APIs or medications for investigational purposes.
We work on providing access to GMP-compliant APIs, placebos and development of IMPs for research purposes and clinical studies.
We develop Investigational Medicinal Products (IMPs) considering all regulatory aspects that will be required for a market authorization in a later phase.
Rediscovering Bisphosphonates.
Bisphosphonates are a versatile therapeutic class that generated products for medical-, dental-, veterinary-, diagnostic-uses, as well as pro-drugs.
Scientific findings predict potential new indications, and our experienced team has a long history in R&D, product development, patenting, and commercialization of bisphosphonates.
We are a leading team with multiple ongoing collaborations with the academia in this field.
Get to know Qualix Ventures
At Qualix Ventures we offer the best of our knowledge and experience to drive the companies of the group and explore new business opportunities. Our goal is to improve access to medicines and provide solutions to the healthcare industry.
Qualix DoT
Qualix DoT is the research and development pharmaceutical company of Qualix Ventures.
The purpose of Qualix DoT is to explore, drive, and collaborate in world-class innovative projects that come from academic or industrial initiatives by mainly repurposing known compounds for new indications.